OTLK News and Press, Outlook Therapeutics Inc. From 04/26/24

2024-04-26 16:40:00 ET More on Outlook Therapeutics Outlook Therapeutics: De-Risked Regulatory Tracks Are Lining Up For Possible ONS-5010 Approval Outlook Therapeutics shares rise after 'buy' rating from BTIG Outlook Therapeutics stock jumps as EU backs new wet AMD t...

ISELIN, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed...

2024-03-31 09:25:35 ET Summary The positive CHMP opinion could mean possible European Approval; European Commission expected to decide upon approval for this in the next few months. Phase 3 NORSE EIGHT study underway using ONS-5010 for the treatment of patients with Wet-AMD; Data ...

2024-03-28 17:15:11 ET More on Outlook Therapeutics Outlook Therapeutics shares rise after 'buy' rating from BTIG Outlook Therapeutics stock jumps as EU backs new wet AMD treatment Read the full article on Seeking Alpha For further details see: Outlook Th...

2024-03-27 13:04:14 ET Read the full article on Seeking Alpha For further details see: Outlook Therapeutics shares rise after "buy" rating from BTIG

2024-03-25 16:54:18 ET More on Outlook Therapeutics Outlook Therapeutics stock jumps as EU backs new wet AMD treatment Outlook Therapeutics falls on 1-for-20 reverse stock split Seeking Alpha’s Quant Rating on Outlook Therapeutics Read the full artic...

2024-03-25 05:23:11 ET More on related stocks: Federal Reserve Talk, Walgreens Earnings And UPS Under The Spotlight DWAC: Trump Merger Could Close Next Week Bringing Volatility Digital World Acquisition: It's Time To Short The Trump Bump (Again) Germany canna...

2024-03-22 13:02:29 ET More on Mid-day movers & stocks. Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Aemetis, Inc. (AMTX) Q4 2023 Earnings Call Transcript Aemetis, Inc. 2023 Q4 - Results - Earnings Call Presentation Aemetis surges after USCIS ap...

A look at the top 10 most actives in the United States Biolase Inc. (BIOL) rose 52.0% to $0.228 on volume of 76,448,685 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 8.5% to $0.1476 on volume of 32,191,096 shares Nova Lifestyle Inc (NVFY) rose 121.6% to $4.1 on volume of 32,...

2024-03-22 08:32:44 ET More on Outlook Therapeutics Outlook Therapeutics falls on 1-for-20 reverse stock split Outlook Therapeutics stock climbs 13% amid Chardan upgrade Seeking Alpha’s Quant Rating on Outlook Therapeutics Historical earnings data for ...